The company expired its plan on December 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.64 CNY | +0.11% | -2.92% | -14.14% |
31/05 | Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Dividend Implementation for 2023, Payable on 06 June 2024 | CI |
06/05 | China Approves Tianyu Pharma's Heart Medication | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.14% | 88Cr | |
+19.70% | 4.35TCr | |
+24.43% | 2.26TCr | |
+16.89% | 1.51TCr | |
+23.26% | 1.48TCr | |
+57.15% | 1.31TCr | |
-0.05% | 678.76Cr | |
-12.44% | 672.38Cr | |
-8.87% | 572.55Cr | |
+12.71% | 545.16Cr |
- Stock Market
- Equities
- 300702 Stock
- News Zhejiang Tianyu Pharmaceutical Co., Ltd.
- Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback announced on June 30, 2022, has expired with 2,403,643 shares, representing 0.69% for CNY 58 million.